OVID

Ovid Therapeutics Inc
NASDAQHEALTHCAREBIOTECHNOLOGY

Key Statistics

Market Cap
$482.77M
P/E Ratio
EPS
$-0.23
Beta
0.18
52W High
$3.10
52W Low
$0.27
50-Day MA
$2.45
200-Day MA
$1.66
Dividend Yield
Profit Margin
-240.10%
Forward P/E
1.79
PEG Ratio
0.00

About Ovid Therapeutics Inc

Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medications for patients and families with neurological disorders in the United States. The company is headquartered in New York, New York.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$7.25M
Gross Profit (TTM)$7.25M
EBITDA$-42.17M
Operating Margin-1712.00%
Return on Equity-17.50%
Return on Assets-21.80%
Revenue/Share (TTM)$0.10
Book Value$1.00
Price-to-Book3.70
Price-to-Sales (TTM)66.57
EV/Revenue58.94
EV/EBITDA-0.69
Quarterly Earnings Growth (YoY)0.00%
Quarterly Revenue Growth (YoY)845.00%
Shares Outstanding$173.04M
Float$113.96M
% Insiders7.53%
% Institutions37.35%

Historical Volatility

HV 10-Day
44.47%
HV 20-Day
46.16%
HV 30-Day
66.08%
HV 60-Day
76.27%
HV Rank

Volatility is currently contracting

Analyst Ratings

Consensus ($5.25 target)
11
Buy

More HEALTHCARE Stocks

Data last updated: 5/14/2026